Role of Nanotechnology in Combating Ischemic Stroke
Role of Nanotechnology in Combating Ischemic Stroke
DOI:
https://doi.org/10.37285/ijpsn.2024.17.5.1Abstract
Introduction
Stroke is a prevalent neurological disorder caused either by an interruption in the brain's blood supply or a loss of vascular integrity, leading to bleeding within brain tissue, and resulting in neuronal damage.
Downloads
Metrics
Keywords:
NANOTECHNOLOGY, STROKE, ISCHEMIC, THERANOSTICS
Published
How to Cite
Issue
Section
References
Dhir N, Medhi B, Prakash A, Goyal MK, Modi M, Mohindra S. Pre-clinical to Clinical Translational Failures and Current Status of Clinical Trials in Stroke Therapy: A Brief Review. Curr Neuropharmacol. 2020;18(7):596–612.
Palmer SJ. Identification, care and prevention of stroke is possible. Br J Healthc Assist. 2023 Jun 2;17(6):236–9.
Salaudeen MA, Bello N, Danraka RN, Ammani ML. Understanding the Pathophysiology of Ischemic Stroke: The Basis of Current Therapies and Opportunity for New Ones. Biomolecules. 2024 Mar 4;14(3):305.
Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke. N Engl J Med. 2013 Mar 7;368(10):893–903.
Al-Ahmady ZS, Jasim D, Ahmad SS, Wong R, Haley M, Coutts G, et al. Selective Liposomal Transport through Blood Brain Barrier Disruption in Ischemic Stroke Reveals Two Distinct Therapeutic Opportunities. ACS Nano. 2019 Nov 26;13(11):12470–86.
van Putten MJAM, Fahlke C, Kafitz KW, Hofmeijer J, Rose CR. Dysregulation of Astrocyte Ion Homeostasis and Its Relevance for Stroke-Induced Brain Damage. Int J Mol Sci. 2021 May 26;22(11):5679.
Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: Overcoming blood–brain barrier to treat neurodegenerative diseases. J Controlled Release. 2016 Aug 10;235:34–47.
Bernardo-Castro S, Albino I, Barrera-Sandoval ÁM, Tomatis F, Sousa JA, Martins E, et al. Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke. Life Basel Switz. 2021 May 26;11(6):482.
Lee N, Yoo D, Ling D, Cho MH, Hyeon T, Cheon J. Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy. Chem Rev. 2015 Oct 14;115(19):10637–89.
Kyle S, Saha S. Nanotechnology for the detection and therapy of stroke. Adv Healthc Mater. 2014 Nov;3(11):1703–20.
Sarmah D, Banerjee M, Datta A, Kalia K, Dhar S, Yavagal DR, et al. Nanotechnology in the diagnosis and treatment of stroke. Drug Discov Today. 2021 Feb 1;26(2):585–92.
Shcharbina N, Shcharbin D, Bryszewska M. Nanomaterials in Stroke Treatment: Perspectives. Stroke. 2013 Aug;44(8):2351–5.
Hammami I, Alabdallah NM, jomaa AA, kamoun M. Gold nanoparticles: Synthesis properties and applications. J King Saud Univ - Sci. 2021 Oct 1;33(7):101560.
Han D, Wang M, Dong N, Zhang J, Li D, Ma X, et al. Selective homing of brain-derived reconstituted lipid nanoparticles to cerebral ischemic area enables improved ischemic stroke treatment. J Controlled Release. 2024 Jan 1;365:957–68.
Fayyazi F, ebrahimi V, Mamaghani MM, Abgharmi BA, Zarrini G, Mosarrezaii A, et al. N-Acetyl cysteine amide and cerium oxide nanoparticles as a drug delivery for ischemic stroke treatment: Inflammation and oxidative stress crosstalk. J Trace Elem Med Biol. 2023 Dec 1;80:127300.
Le N, Kim K. Current Advances in the Biomedical Applications of Quantum Dots: Promises and Challenges. Int J Mol Sci. 2023 Aug 11;24(16):12682.
Costantino L, Boraschi D. Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents? Drug Discov Today. 2012 Apr 1;17(7):367–78.
Landowski LM, Niego B, Sutherland BA, Hagemeyer CE, Howells DW. Applications of Nanotechnology in the Diagnosis and Therapy of Stroke. Semin Thromb Hemost. 2020 Jul;46(5):592–605.
Kane AB, Hurt RH, Gao H. The asbestos-carbon nanotube analogy: An update. Toxicol Appl Pharmacol. 2018 Dec 15;361:68–80.
Bonnard T, Gauberti M, Martinez de Lizarrondo S, Campos F, Vivien D. Recent Advances in Nanomedicine for Ischemic and Hemorrhagic Stroke. Stroke. 2019 May;50(5):1318–24.
